| Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
days
| 8 |
7.67 |
mg/dl |
0.55 |
1.55 |
liquid phase colorimetry |
0.0 |
|
75949 |
1542 |
| Hsd:WI |
plasma uric acid level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood uric acid amount |
male |
days
| 8 |
4.89 |
mg/dl |
0.35 |
0.98 |
liquid phase colorimetry |
0.0 |
|
75950 |
1542 |
| Hsd:WI |
plasma urea nitrogen level |
lactotransferrin (300 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood urea nitrogen amount |
male |
53.0 days
| 6 |
6.52 |
mmol/l |
0.59 |
1.45 |
plasma urea nitrogen analysis |
0.0 |
|
76058 |
1547 |
| Hsd:WI |
kidney platinum level |
0.9% sodium chloride solution (3 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
kidney molecular composition trait |
male |
53.0 days
| 10 |
16.7 |
ug/g |
1.96 |
6.2 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
76063 |
1547 |
| Hsd:WI |
body weight |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
days
| 6 |
142.5 |
g |
0.73 |
1.8 |
body weighing method |
0.0 |
|
75953 |
1544 |
| Hsd:WI |
serum creatinine level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
days
| 6 |
1.11 |
mg/dl |
0.25 |
0.62 |
serum creatinine analysis |
0.0 |
|
75974 |
1544 |
| Hsd:WI |
serum urea nitrogen level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
days
| 6 |
75.2 |
mg/dl |
2.16 |
5.3 |
liquid phase colorimetry |
0.0 |
|
75979 |
1544 |
| Hsd:WI |
serum urea nitrogen level |
lycopene (6 mg/kg/d) (for 12 days) then cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood urea nitrogen amount |
not specified |
78.0 days
| 7 |
62.43 |
mg/dl |
5.35 |
14.15 |
serum urea analysis |
0.0 |
|
76049 |
1546 |
| Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
2.92 |
null |
0.11 |
0.32 |
liquid phase colorimetry |
0.0 |
|
76220 |
1542 |
| Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
18.63 |
null |
0.61 |
1.73 |
liquid phase colorimetry |
0.0 |
|
76224 |
1542 |
| Hsd:WI |
both kidneys wet weight |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney mass |
male |
days
| 6 |
1.2 |
g |
0.05 |
0.13 |
post excision weight measurement |
0.0 |
|
75957 |
1544 |
| Hsd:WI |
kidney lipid peroxide level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
days
| 6 |
0.83 |
nmol/mg |
0.04 |
0.09 |
liquid phase colorimetry |
0.0 |
|
76258 |
1544 |
| Hsd:WI |
plasma urea nitrogen level |
0.9% sodium chloride solution (3 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood urea nitrogen amount |
male |
55.0 days
| 6 |
44.38 |
mmol/l |
4.07 |
9.96 |
plasma urea nitrogen analysis |
0.0 |
|
76052 |
1547 |
| Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
days
| 6 |
8.13 |
U/mg |
0.79 |
1.94 |
liquid phase colorimetry |
0.0 |
|
76188 |
1544 |
| Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
days
| 6 |
10.11 |
U/mg |
0.22 |
0.54 |
liquid phase colorimetry |
0.0 |
|
76189 |
1544 |
| Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
days
| 8 |
108.4 |
ug/g |
4.56 |
12.9 |
liquid phase colorimetry |
0.0 |
|
76232 |
1542 |
| Hsd:WI |
kidney catalase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
days
| 6 |
30.56 |
nmol/mg |
0.37 |
0.9 |
liquid phase colorimetry |
0.0 |
|
76237 |
1544 |
| Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
days
| 8 |
14.83 |
U/mg |
0.43 |
1.21 |
liquid phase colorimetry |
0.0 |
|
76212 |
1542 |
| Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
days
| 8 |
62.54 |
null |
2.21 |
6.24 |
liquid phase colorimetry |
0.0 |
|
76215 |
1542 |
| Hsd:WI |
body weight |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
days
| 6 |
143.6 |
g |
0.41 |
1.0 |
body weighing method |
0.0 |
|
75954 |
1544 |
| Hsd:WI |
timed urine volume |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
9.2 |
ml/d |
0.69 |
1.7 |
urine volume measurement method |
0.0 |
|
75968 |
1544 |
| Hsd:WI |
kidney glutathione level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione amount |
male |
days
| 8 |
58.72 |
ug/g |
3.78 |
10.7 |
liquid phase colorimetry |
0.0 |
|
76231 |
1542 |
| Hsd:WI |
plasma urea nitrogen level |
0.9% sodium chloride solution (3 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood urea nitrogen amount |
male |
53.0 days
| 6 |
8.68 |
mmol/l |
0.66 |
1.63 |
plasma urea nitrogen analysis |
0.0 |
|
76056 |
1547 |
| Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
days
| 8 |
20.62 |
mmol/l |
1.27 |
3.61 |
liquid phase colorimetry |
0.0 |
|
75941 |
1542 |
| Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
days
| 6 |
13.39 |
U/mg |
0.09 |
0.21 |
liquid phase colorimetry |
0.0 |
|
76193 |
1544 |
| Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
days
| 6 |
15.4 |
U/mg |
0.29 |
0.71 |
liquid phase colorimetry |
0.0 |
|
76194 |
1544 |
| Hsd:WI |
kidney platinum level |
lactotransferrin (300 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
kidney molecular composition trait |
male |
53.0 days
| 10 |
9.8 |
ug/g |
2.1 |
6.64 |
inductively coupled plasma-atomic emission spectrometry |
0.0 |
|
76064 |
1547 |
| Hsd:WI |
both kidneys wet weight |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney mass |
male |
days
| 6 |
0.86 |
g |
0.03 |
0.07 |
post excision weight measurement |
0.0 |
|
75958 |
1544 |
| Hsd:WI |
both kidneys wet weight |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney mass |
male |
days
| 6 |
0.84 |
g |
0.03 |
0.08 |
post excision weight measurement |
0.0 |
|
75959 |
1544 |
| Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
days
| 8 |
1.67 |
mg/dl |
0.12 |
0.33 |
liquid phase colorimetry |
0.0 |
|
75946 |
1542 |
| Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
450.1 |
U/mg |
3.15 |
8.91 |
liquid phase colorimetry |
0.0 |
|
76201 |
1542 |
| Hsd:WI |
kidney catalase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
days
| 6 |
21.73 |
nmol/mg |
0.62 |
1.51 |
liquid phase colorimetry |
0.0 |
|
76235 |
1544 |
| Hsd:WI |
kidney glutathione level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
days
| 6 |
10012.49 |
ug/g |
293.58 |
719.13 |
liquid phase colorimetry |
0.0 |
|
76240 |
1544 |
| Hsd:WI |
serum creatinine level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
days
| 6 |
0.85 |
mg/dl |
0.03 |
0.08 |
serum creatinine analysis |
0.0 |
|
75975 |
1544 |
| Hsd:WI |
serum urea nitrogen level |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
days
| 6 |
89.7 |
mg/dl |
2.9 |
7.11 |
liquid phase colorimetry |
0.0 |
|
75978 |
1544 |
| Hsd:WI |
serum creatinine level |
cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78.0 days
| 7 |
1.37 |
mg/dl |
0.21 |
0.56 |
serum creatinine analysis |
0.0 |
|
76040 |
1546 |
| Hsd:WI |
serum creatinine level |
lycopene (6 mg/kg/d) (for 12 days) then cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood creatinine amount |
not specified |
78.0 days
| 7 |
0.4 |
mg/dl |
0.01 |
0.03 |
serum creatinine analysis |
0.0 |
|
76043 |
1546 |
| Hsd:WI |
kidney glutathione level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
days
| 6 |
9864.97 |
ug/g |
200.74 |
491.71 |
liquid phase colorimetry |
0.0 |
|
76241 |
1544 |
| Hsd:WI |
kidney lipid peroxide level |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
days
| 6 |
0.88 |
nmol/mg |
0.02 |
0.06 |
liquid phase colorimetry |
0.0 |
|
76259 |
1544 |
| Hsd:WI |
body weight |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
body mass |
male |
days
| 6 |
137.6 |
g |
0.45 |
1.1 |
body weighing method |
0.0 |
|
75952 |
1544 |
| Hsd:WI |
timed urine volume |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
10.0 |
ml/d |
0.78 |
1.9 |
urine volume measurement method |
0.0 |
|
75967 |
1544 |
| Hsd:WI |
serum urea nitrogen level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood urea nitrogen amount |
male |
days
| 6 |
96.11 |
mg/dl |
1.91 |
4.69 |
liquid phase colorimetry |
0.0 |
|
75977 |
1544 |
| Hsd:WI |
kidney glutathione peroxidase activity to total protein level ratio |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione peroxidase activity |
male |
days
| 6 |
7.54 |
U/mg |
0.51 |
1.24 |
liquid phase colorimetry |
0.0 |
|
76192 |
1544 |
| Hsd:WI |
plasma urea nitrogen level |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood urea nitrogen amount |
male |
days
| 8 |
14.48 |
mmol/l |
0.88 |
2.49 |
liquid phase colorimetry |
0.0 |
|
75942 |
1542 |
| Hsd:WI |
kidney glutathione level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney glutathione amount |
male |
days
| 6 |
7882.76 |
ug/g |
178.16 |
436.39 |
liquid phase colorimetry |
0.0 |
|
76239 |
1544 |
| Hsd:WI |
plasma creatinine level |
0.9% sodium chloride solution (3 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood creatinine amount |
male |
53.0 days
| 6 |
0.31 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
0.0 |
|
76060 |
1547 |
| Hsd:WI |
kidney lipid peroxide level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney lipid peroxide amount |
male |
days
| 6 |
1.51 |
nmol/mg |
0.03 |
0.08 |
liquid phase colorimetry |
0.0 |
|
76257 |
1544 |
| Hsd:WI |
kidney paraoxonase1 activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney paraoxonase 1 activity |
male |
days
| 8 |
9.57 |
U/mg |
0.3 |
0.86 |
liquid phase colorimetry |
0.0 |
|
76211 |
1542 |
| Hsd:WI |
plasma creatinine level |
0.9% sodium chloride solution (3 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood creatinine amount |
male |
55.0 days
| 6 |
2.56 |
mg/dl |
0.17 |
0.42 |
plasma creatinine analysis |
0.0 |
|
76054 |
1547 |
| Hsd:WI |
plasma creatinine level |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
blood creatinine amount |
male |
days
| 8 |
2.85 |
mg/dl |
0.25 |
0.71 |
liquid phase colorimetry |
0.0 |
|
75945 |
1542 |
| Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
292.4 |
U/mg |
14.25 |
40.3 |
liquid phase colorimetry |
0.0 |
|
76202 |
1542 |
| Hsd:WI |
kidney catalase activity to total protein level ratio |
1H-pyrazole (10 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
catalase activity |
male |
days
| 6 |
23.2 |
nmol/mg |
0.29 |
0.7 |
liquid phase colorimetry |
0.0 |
|
76236 |
1544 |
| Hsd:WI |
kidney glutathione peroxidase activity to glutathione reductase activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney glutathione peroxidase activity |
male |
days
| 8 |
46.14 |
null |
1.7 |
4.82 |
liquid phase colorimetry |
0.0 |
|
76216 |
1542 |
| Hsd:WI |
plasma creatinine level |
lactotransferrin (300 mg/kg/d) (for 6 days) then cisplatin (7 mg/kg) |
Kimoto Y, et al., J Vet Med Sci. 2013 Feb;75(2):159-64. Epub 2012 Oct 10. |
blood creatinine amount |
male |
53.0 days
| 6 |
0.15 |
mg/dl |
0.02 |
0.05 |
plasma creatinine analysis |
0.0 |
|
76062 |
1547 |
| Hsd:WI |
kidney superoxide dismutase activity to total protein level ratio |
silymarin (50 mg/kg/d) (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
kidney superoxide dismutase activity |
male |
days
| 6 |
11.74 |
U/mg |
0.56 |
1.38 |
liquid phase colorimetry |
0.0 |
|
76190 |
1544 |
| Hsd:WI |
timed urine volume |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
urine output |
male |
days
| 6 |
21.8 |
ml/d |
1.31 |
3.2 |
urine volume measurement method |
0.0 |
|
75966 |
1544 |
| Hsd:WI |
serum creatinine level |
vehicle control condition (for 10 days) then cisplatin (7.5 mg/kg) |
Prabhu VV, et al., Pharmacol Rep. 2013;65(4):980-90. |
blood creatinine amount |
male |
days
| 6 |
1.69 |
mg/dl |
0.06 |
0.14 |
serum creatinine analysis |
0.0 |
|
75973 |
1544 |
| Hsd:WI |
serum urea nitrogen level |
cisplatin (7 mg/kg) |
Erman F, et al., Biol Trace Elem Res. 2014 Feb 16. |
blood urea nitrogen amount |
not specified |
78.0 days
| 7 |
124.33 |
mg/dl |
12.59 |
33.31 |
serum urea analysis |
0.0 |
|
76048 |
1546 |
| Hsd:WI |
kidney superoxide dismutase to catalase activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
6.67 |
null |
0.3 |
0.85 |
liquid phase colorimetry |
0.0 |
|
76219 |
1542 |
| Hsd:WI |
kidney superoxide dismutase to glutathione peroxidase ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
35.78 |
null |
1.46 |
4.14 |
liquid phase colorimetry |
0.0 |
|
76223 |
1542 |
| Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
47.04 |
null |
2.0 |
5.65 |
liquid phase colorimetry |
0.0 |
|
76227 |
1542 |
| Hsd:WI |
kidney superoxide dismutase to paraoxonase1 activity ratio |
cisplatin (3 mg/kg) (for 25 days) and benfotiamine (100 mg/kg/d) (for 25 days) |
Harisa GI J Biochem Mol Toxicol. 2013 Aug;27(8):398-405. doi: 10.1002/jbt.21501. Epub 2013 May 28. |
kidney superoxide dismutase activity |
male |
days
| 8 |
19.72 |
null |
0.82 |
2.31 |
liquid phase colorimetry |
0.0 |
|
76228 |
1542 |